History: Predicting the efficacy of antiangiogenic therapy would be of clinical

History: Predicting the efficacy of antiangiogenic therapy would be of clinical value in patients (pts) with metastatic renal cell carcinoma (mRCC). day 14 during treatment (46 pts received sunitinib and 9 pts received sorafenib). Circulating endothelial cells (CD45?Compact disc31+Compact disc146+7-amino-actinomycin (7AAD)? cells) were measured in 1?ml entire blood using four-color flow cytometry (FCM). Circulating Compact… Continue reading History: Predicting the efficacy of antiangiogenic therapy would be of clinical